Skip to main content
. 2021 May 6;7(7):993–1003. doi: 10.1001/jamaoncol.2021.1074

Figure. Autologous Hematopoietic Cell Transplant Outcomes for Patients With Primary Central Nervous System Lymphoma.

Figure.

BEAM indicates carmustine, etoposide, cytarabine, melphalan; TBC, thiotepa, busulfan, cyclophosphamide; TT-BCNU, thiotepa, carmustine.